The research group of Prof. Wanliang Lu has made progress in the research of genetically engineered PD1 protein preparations in cancer immunotherap

Journal of Chinese Pharmaceutical Sciences ›› 2024, Vol. 33 ›› Issue (2): 178-179.

The research group of Prof. Wanliang Lu has made progress in the research of genetically engineered PD1 protein preparations in cancer immunotherap

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2024-02-25 Revised:2024-02-25 Accepted:2024-02-25 Online:2024-03-03 Published:2024-03-09

Abstract

Supporting:

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research group of Prof. Wanliang Lu has made progress in the research of genetically engineered PD1 protein preparations in cancer immunotherap[J]. Journal of Chinese Pharmaceutical Sciences, 2024, 33(2): 178-179.

The research group of Prof. Wanliang Lu has made progress in the research of genetically engineered PD1 protein preparations in cancer immunotherap

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics

Comments